Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1Head and Neck Neoplasms 1

Interventions

Carboplatin 49Etoposide 46Cisplatin 42Topotecan 39Irinotecan 21Paclitaxel 20Nivolumab 15pembrolizumab 13Gemcitabine 13atezolizumab 11Ipilimumab 11durvalumab 9Radiotherapy 9Doxorubicin 7Bevacizumab 7rovalpituzumab tesirine 6etoposide phosphate 6amrubicin 6Psychiatric Rehabilitation 6PM 01183 6Docetaxel 6Counseling 6trilaciclib 5Temozolomide 5Sunitinib 5Platinum 5Imatinib Mesylate 5Cyclophosphamide 5Bortezomib 5130-nm albumin-bound paclitaxel 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Small Cell Lung Carcinoma × phenethyl isothiocyanate × Clear all
NCT00691132 2017-05-12

Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers

University of Minnesota

Phase 2 Completed
107 enrolled 18 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tobacco Use Disorder, Small Cell Lung Carcinoma

NCT00005883 2011-03-28

Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke

NYU Langone Health

Phase 1 Completed
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡